As the global countries are scrambling to find a cure for the devastating COVID-19, the US researchers stood ahead by giving an experimental dose to the first participant in the clinical trial for a vaccine against COVID-19.<\/p>\n
Jennifer Haller, 43, of Seattle, received the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle on March 16, 2020.<\/p>\n
A total of 45 young, healthy volunteers will receive two doses, a month apart to test the safety of the vaccine as well as its ability to induce an immune response in the volunteers.<\/p>\n
\nU.S. researchers began the first human trial of a #coronavirus<\/a> vaccine
\nMore via @business<\/a>: https:\/\/t.co\/RE9iBE3nGL<\/a> pic.twitter.com\/Di8gn8qgBZ<\/a><\/p>\n\u2014 QuickTake by Bloomberg (@QuickTake) March 17, 2020<\/a><\/p><\/blockquote>\n